Vimarsana
Biggest News Aggregation in the World

Servier Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Servier Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Servier Group Today - Breaking & Trending Today

French Barrier: Indian Cos Face French Barrier For Generic Deal | India Business News - Vimarsana News

French Barrier: Indian Cos Face French Barrier For Generic Deal | India Business News

India Business News: NEW DELHI: You can call it a Swadeshi spirit in French style.

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma - Vimarsana News

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma

/PRNewswire/ -- Servier, a global leader in oncology focused on delivering meaningful therapeutic progress for the patients it serves, today announced the FDA...

Servier Showcases Leadership in Mutant Isocitrate Dehydrogenase (IDH) Inhibition Through New Data Spotlighting Real-World Treatment Patterns and Clinical Outcomes of Tibsovo® Use at ASH 2023 - Vimarsana News

Servier Showcases Leadership in Mutant Isocitrate Dehydrogenase (IDH) Inhibition Through New Data Spotlighting Real-World Treatment Patterns and Clinical Outcomes of Tibsovo® Use at ASH 2023

/PRNewswire/ -- Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, will be presenting new data in acute...

New Vorasidenib Data at SNO 2023 Bolster Servier's Neuro-Oncology Clinical Development Program - Vimarsana News

New Vorasidenib Data at SNO 2023 Bolster Servier's Neuro-Oncology Clinical Development Program

/PRNewswire/ -- Servier will showcase new data from its vorasidenib clinical development program in a plenary townhall at the 28th Annual Meeting of the...

Budapest Based Pharmaceutical Giant Gets Key Role in Central Asia - Vimarsana News

Budapest Based Pharmaceutical Giant Gets Key Role in Central Asia

Egis Pharmaceuticals Zrt. announced that it has signed a cooperation agreement with the Uzbek pharmaceutical authority in Tashkent.